[Form 4] LivePerson Inc Insider Trading Activity

Rhea-AI Filing Summary

Anthony Zingale, a director of LivePerson, Inc. (LPSN), was granted a stock option on 08/25/2025 to purchase 400,000 shares of common stock at an exercise price of $1.08 per share under the LivePerson, Inc. 2019 Stock Incentive Plan. The option vests in three equal annual installments beginning on the first anniversary of 08/25/2025 and expires on 08/25/2035. Following the grant, the reporting person is shown as beneficially owning the 400,000 underlying shares (direct ownership of the option). The Form 4 was signed by an attorney-in-fact on 08/27/2025.

Positive

• Director alignment: Grant vests over three years, aligning the director’s incentives with the company’s longer-term performance
• Clear terms disclosed: Exercise price ($1.08), grant date (08/25/2025), vesting schedule, and expiration (08/25/2035) are explicitly stated

Negative

• Potential dilution: The option covers 400,000 shares which could dilute existing shareholders if exercised
• Concentration of award: A single large grant to a director may materially affect executive compensation totals and warrants disclosure

Insights

Financial Analyst

TL;DR A director received a large option grant that could align incentives but will dilute if exercised.

The 400,000-share option at $1.08 is sizable relative to most equity grants and creates potential future dilution if exercised. Vesting over three years ties retention and performance to continued service for the director. The long expiration to 2035 gives flexibility for exercise timing. The grant itself is not a cash expense today but will impact share count if exercised; investors should note the strike price and vesting schedule when modeling potential dilution.

Corporate Governance Expert

TL;DR Standard director equity award with multi-year vesting; aligns interests but warrants disclosure review.

The option was granted under the company’s 2019 plan with customary multi-year vesting, indicating alignment of the director’s incentives with long-term shareholder value. The grant date, exercise price of $1.08, and clear vesting schedule are properly disclosed on Form 4. From a governance perspective, the size of the award is material enough to require monitoring of overall equity compensation run rate and cumulative dilution from insider option exercises.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZINGALE ANTHONY

(Last) (First) (Middle)

C/O LIVEPERSON, INC.

530 7TH AVE., FLOOR M1

(Street)

NEW YORK NY 10018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LIVEPERSON INC [ LPSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.08	08/25/2025		A		400,000		(1)	08/25/2035	Common Stock	400,000	$0	400,000	D

Explanation of Responses:

1. The Reporting Person was granted an option to purchase 400,000 shares of the Issuer's common stock under the terms of the LivePerson, Inc. 2019 Stock Incentive Plan. The option will become exercisable in equal installments on each of the first, second and third anniversaries of August 25, 2025.

Remarks:

	/s/ Monica L. Greenberg, Attorney-in-Fact for Anthony Zingale	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LivePerson director Anthony Zingale receive on 08/25/2025 (LPSN)?

He was granted a stock option to purchase 400,000 shares of LivePerson common stock at an exercise price of $1.08 per share.

When does the option granted to Anthony Zingale vest and expire?

The option vests in three equal installments on each of the first, second and third anniversaries of 08/25/2025 and expires on 08/25/2035.

How many shares does Anthony Zingale beneficially own following the reported transaction?

The Form 4 reports beneficial ownership of the 400,000 underlying shares represented by the option following the grant.

What is the exercise price of the option and under which plan was it granted?

The exercise price is $1.08 and the option was granted under the LivePerson, Inc. 2019 Stock Incentive Plan.

Who signed the Form 4 filing for Anthony Zingale and when?

The Form 4 was signed by Monica L. Greenberg, Attorney-in-Fact for Anthony Zingale on 08/27/2025.